Telangana’s life sciences ecosystem has reached a landmark $145 billion valuation, marking a major milestone in India’s pharmaceutical and biotechnology sectors. The achievement comes amid rising investments, policy support, and Hyderabad’s emerge...
The Bajaj Group’s ?2,000 crore healthcare bet is officially underway in Pune, as the diversified conglomerate prepares to enter India’s healthcare sector with an ambitious long-term expansion strategy. The group plans to invest over ?2,000 crore...
An experimental Alzheimer’s drug is advancing despite a trial miss, keeping the Tau Therapy Race alive. The Alzheimer’s drug, designed to target the tau protein linked to cognitive decline, delivered mixed mid-stage results but showed enough...
As temperatures across Delhi-NCR hover above 40°C, hospitals are reporting a sharp increase in dehydration kidney problems, with doctors warning of serious renal health risks from the ongoing heatwave.
Swiss pharma giant Roche has introduced Tecentriq SC in India, a faster subcutaneous version of its blockbuster lung cancer treatment that can be administered in just seven minutes.
The Pharma Quality Excellence Awards 2026 marked another significant milestone in recognizing excellence in pharmaceutical quality and innovation. Hosted at Hotel Westin Mumbai Garden City
At a time when the pharmaceutical industry is navigating increasing regulatory scrutiny, rapid digitalization, and growing expectations around trust and transparency, the conversation around quality is evolving.
Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences, has signed a deal with Assertio Holdings, Inc., through its wholly-owned subsidiary, Zara Merger Sub Inc., marking its entry into the US Oncology market.
Alembic Pharma shares gained attention on Wednesday after the company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) for Darolutamide Tablets 300 mg, a treatment used for prostate cancer.
Tata Group’s Arthritis Drug Deal with Vyome Holdings marks a major step in India’s growing biotech and pharmaceutical innovation space. The Arthritis Drug Deal involves Tata-backed Impetis Biosciences out-licensing two experimental drugs designed...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")